These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31844581)

  • 1. Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension.
    Wei J; Zhou Z; Xu Z; Zeng S; Chen X; Wang X; Liu W; Liu M; Gong Z; Yan Y
    PeerJ; 2019; 7():e8188. PubMed ID: 31844581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib.
    Aydiner A; Ciftci R; Sen F
    Medicine (Baltimore); 2015 Jun; 94(22):e887. PubMed ID: 26039117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of Renin-angiotensin System Blockage on Recurrence of Non-muscle-invasive Bladder Cancer].
    Bai YJ; Wang XM; Han P; Yang YB; Tang Y; Wei Q; Wang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):635-639. PubMed ID: 30378319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome.
    Li XY; Sun JF; Hu SQ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1375-1383. PubMed ID: 28387887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs).
    Alashkham A; Paterson C; Windsor P; Struthers A; Rauchhaus P; Nabi G
    Clin Genitourin Cancer; 2016 Oct; 14(5):398-405. PubMed ID: 27053500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension.
    Tian C; Li N; Bai Y; Xiao H; Li S; Ge QG; Shen N; Ma QB
    World J Clin Cases; 2021 Jan; 9(1):47-60. PubMed ID: 33511171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan.
    Tsuchimoto A; Masutani K; Ueki K; Nakagawa K; Matsukuma Y; Tanaka S; Unagami K; Kakuta Y; Okumi M; Noguchi H; Kaku K; Okabe Y; Nakano T; Kitazono T; Nakamura M; Ishida H; Tanabe K;
    Clin Exp Nephrol; 2020 Apr; 24(4):369-378. PubMed ID: 31875930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.
    Zhou Q; Chen DS; Xin L; Zhou LQ; Zhang HT; Liu L; Yuan YW; Li SH
    Medicine (Baltimore); 2020 Feb; 99(7):e19075. PubMed ID: 32049809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset.
    Yang J; Gao Y; Duan Q; Qiu Y; Feng S; Zhan C; Huang Y; Zhang Y; Ma G; Nie K; Wang L
    Parkinsonism Relat Disord; 2022 Dec; 105():90-95. PubMed ID: 36395543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
    Pirola CJ; Sookoian S
    J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
    Powers B; Greene L; Balfe LM
    J Manag Care Pharm; 2011 Oct; 17(8 Suppl):S1-14. PubMed ID: 22088101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study.
    Yahyavi A; Hemmati N; Derakhshan P; Banivaheb B; Karimi Behnagh A; Tofighi R; TehraniYazdi A; Kabir A
    Intern Emerg Med; 2021 Jun; 16(4):883-893. PubMed ID: 33085063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients.
    Nagai Y; Yamabe F; Sasaki Y; Ishii T; Nakanishi K; Nakajima K; Shibuya K; Mikami T; Akasaka Y; Urita Y; Yamanaka N
    Kidney Blood Press Res; 2020; 45(2):194-208. PubMed ID: 31945766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.
    Huang J; Buckley NA; Isoardi KZ; Chiew AL; Isbister GK; Cairns R; Brown JA; Chan BS
    Clin Toxicol (Phila); 2021 Jun; 59(6):464-471. PubMed ID: 33021397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
    Graham DJ; Izurieta HS; Muthuri SG; Zhang D; Sandhu AT; Lu Y; Zhao Y; Feng Y; Eworuke E; Lyu H; Gandotra C; Smith ER; Avagyan A; Wernecke M; Kelman JA; Forshee RA; MaCurdy TE
    J Gen Intern Med; 2021 Dec; 36(12):3802-3809. PubMed ID: 34599472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.